| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |